See more : Atlantic American Corporation (AAME) Income Statement Analysis – Financial Results
Complete financial analysis of Avisa Diagnostics Inc. (AVBT.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Avisa Diagnostics Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Agro Capital Management Corp. (ACMB) Income Statement Analysis – Financial Results
- Qell Acquisition Corp. (QELLU) Income Statement Analysis – Financial Results
- The Charles Schwab Corporation (SCHW-PD) Income Statement Analysis – Financial Results
- Mizrahi Tefahot Bank Ltd. (MZTFF) Income Statement Analysis – Financial Results
- Zinzino AB (publ) (ZZ-B.ST) Income Statement Analysis – Financial Results
Avisa Diagnostics Inc. (AVBT.CN)
About Avisa Diagnostics Inc.
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 277.83K | 838.86K | 194.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 148.55K | 407.05K | 93.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 129.28K | 431.81K | 100.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 46.53% | 51.48% | 51.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.05M | 2.57M |
| General & Administrative | 859.98K | 2.08M | 4.76M | 26.31K | 0.00 | 54.71K | 269.30K | 508.60K | 1.46M | 1.63M | 5.23M | 1.54M | 2.16M |
| Selling & Marketing | 3.56K | 36.76K | 118.26K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 863.53K | 2.12M | 4.88M | 26.31K | 88.37K | 54.71K | 269.30K | 508.60K | 1.46M | 1.63M | 5.23M | 1.54M | 2.16M |
| Other Expenses | -35.09K | 965.67K | 1.21M | 0.00 | 0.00 | 0.00 | 0.00 | 127.06K | 1.02M | 2.45M | 24.72K | 65.11K | 53.78K |
| Operating Expenses | 828.44K | 3.08M | 6.09M | 26.31K | 88.37K | 54.71K | 269.30K | 635.66K | 2.48M | 4.08M | 5.26M | 3.66M | 4.79M |
| Cost & Expenses | 976.99K | 3.49M | 6.18M | 26.31K | 88.37K | 54.71K | 269.30K | 635.66K | 2.48M | 4.08M | 5.26M | 3.66M | 4.79M |
| Interest Income | 497.00 | 2.00K | 6.51K | 0.00 | 0.00 | 0.00 | 62.88 | 0.00 | 0.00 | 0.00 | 29.86K | 4.07K | 13.75K |
| Interest Expense | 17.10K | 0.00 | 6.51K | 0.00 | 0.00 | 0.00 | 62.88 | 0.00 | 25.08K | 14.35K | 113.37K | 4.07K | 4.81K |
| Depreciation & Amortization | 20.52K | 2.45M | 1.21M | -18.57K | 303.55 | 442.24K | -14.55K | 601.07 | 3.51K | 5.05K | 18.07K | 15.69K | 11.95K |
| EBITDA | -678.64K | -198.84K | -5.28M | -44.88K | -88.07K | 387.52K | -283.85K | -1.30M | -5.36M | -4.30M | -5.28M | -3.63M | -4.89M |
| EBITDA Ratio | -244.26% | -23.70% | -2,717.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -699.16K | -2.65M | -3.40M | -26.31K | -88.37K | -54.71K | -269.30K | -1.26M | -5.34M | -4.13M | -5.37M | -3.66M | -4.79M |
| Operating Income Ratio | -251.65% | -315.93% | -1,749.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -16.60K | -1.48M | -3.10M | -18.57K | 303.55 | 442.24K | -14.61K | -45.78K | -50.59K | -191.18K | -44.23K | 4.07K | -116.52K |
| Income Before Tax | -715.76K | -4.13M | -6.50M | -44.88K | -88.07K | 387.52K | -283.91K | -1.30M | -5.39M | -4.32M | -5.42M | -3.65M | -4.91M |
| Income Before Tax Ratio | -257.63% | -492.80% | -3,342.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 17.10K | 1.48M | -3.09M | 0.00 | 0.00 | 0.00 | -62.07K | -45.78K | -47.73K | -10.72K | -24.19K | -195.63K | -667.57K |
| Net Income | -732.86K | -5.62M | -6.50M | -44.88K | -88.07K | 387.52K | -221.84K | -1.30M | -5.34M | -4.31M | -5.39M | -3.46M | -4.24M |
| Net Income Ratio | -263.78% | -669.67% | -3,342.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.14 | -1.14 | -1.56 | -0.35 | -1.25 | 6.57 | -4.19 | -24.95 | -161.93 | -210.84 | -295.94 | -304.32 | -678.26 |
| EPS Diluted | -0.14 | -1.14 | -1.56 | -0.35 | -1.25 | 6.57 | -4.19 | -24.95 | -161.93 | -210.84 | -295.94 | -304.32 | -678.26 |
| Weighted Avg Shares Out | 5.22M | 4.92M | 4.16M | 129.14K | 70.60K | 59.01K | 52.89K | 52.16K | 32.98K | 20.44K | 18.22K | 11.36K | 6.25K |
| Weighted Avg Shares Out (Dil) | 5.22M | 4.92M | 4.16M | 129.14K | 70.60K | 59.01K | 52.89K | 52.16K | 32.98K | 20.44K | 18.22K | 11.36K | 6.25K |
Source: https://incomestatements.info
Category: Stock Reports